DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5bt9dz/chinese_animal) has announced the addition of the "Chinese Animal Vaccine Industry - 2015" report to their offering.
From 2001, FMD, HPAI, PRRS and Swine were respectively been included in compulsory immunity vaccines, meanwhile, China's animal vaccine industry experienced a rapid development with a CAGR of 19.2 from 2000 to 2014. Currently the market size of China's animal vaccine industry has exceeded RMB 9 billion, which mainly formed up by pig and poultry vaccines with a respectively market share of 49% and 40% in 2014.
FMD Vaccine:
Currently there are only 7 enterprises received the official approval, including one that has not yet been put into production. CAHIC accounts for the largest share of the relatively stable governmental tender vaccine. For market-oriented vaccine, products from Jinyu Group are always in the state that lags behind demand.
HPAI Vaccine:
Currently there are 9 enterprises in this segment, HPAI sales would most probably exceed RMB 2 billion in 2015. Suspension cultivation will be the most promising direction in HPAI vaccine. Liaoning Yikang Biological Corporation Limited is the leading domestic enterprise in suspension cultivation.
PRRS Vaccine:
Porcine reproductive and respiratory syndrome would most probably no longer been an option of compulsory immunity in the near future. The existing inactivated and activated vaccines are still controversial nowadays. Gene engineering vaccine may achieve the break in this segment.
PCV Vaccine:
As the largest part of conventional vaccines, PCV came into market in 2010 with high price and low market penetration rate till now. China PCV market is led by Boehringer Ingelheim. Domestic enterprises such as Jinyu Group are now successively publishing relative gene engineering vaccines.
Swine Vaccine:
The tender price continuously decreasing and will be the first to be removed from compulsory immunity lists.
Key Topics Covered:
Executive Summary
1. Analysis of Animal Vaccine Industry
1.1 International Animal Vaccine Industry
1.2 Chinese Animal Vaccine Industry
2. Development Environment of China Animal Vaccine Industry
2.1 Policy
2.1.1 Major Policies
2.1.2 Compulsory Immunization Vaccine Tender System
2.2 Social Environment
2.2.1 Breeding Industry is Developing Steadily
2.2.2 Large-scale Breeding Becomes a Trend
2.2.3 Animal Epidemics Occur Frequently
3. Prospects of China Animal Vaccine Industry
3.1 Overall Forecast
3.2 Swine Vaccine
3.3 Poultry Vaccine
3.4 Cattle & Sheep Vaccine
3.5 Pet Vaccine
4. Major Companies
- Boehringer Ingelheim
- Chengdu Huasun Group Inc. Ltd.
- China Animal Husbandry Industry Co., Ltd. (CAHIC)
- Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
- Inner Mongolia Jinyu Group Stock Company
- Jinyu Group
- Liaoning Yikang Biological Corporation Limited
- Ningbo TECH-BANK Co., Ltd.
- Shanghai HILE Bio-Technology Co., Ltd.
- Tianjin Ringpu Bio-technology Co., Ltd.
- Wuhan Chopper Biology Co., Ltd.
- Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
- Zhejiang Shenghua Biok Biology Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/5bt9dz/chinese_animal
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
